Impact of COVID-19 pandemic on pharmaceutical systems and supply chain – a phenomenological study

Background: Resilient pharmaceutical systems and supply chains are critical in the control of COVID-19, a pandemic that has mostly devastated public health systems and livelihoods in resource-limited countries in sub-Saharan Africa. Objective: To evaluate the impact of COVID-19 on pharmaceutical sys...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tafadzwa Tirivangani, BPharm, Bertha Alpo, BPharm, Dan Kibuule, BPharm; MSc; PhD, Johannes Gaeseb, BPharm; MPH, Babafunso A. Adenuga, BPharm; MPH; PhD
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	COVID-19 Pandemic Pharmaceutical sector Lockdowns Pharmacy and materia medica RS1-441
Acceso en línea:	https://doaj.org/article/176357faa9ec4fb7bc0edb19b50aae25
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:176357faa9ec4fb7bc0edb19b50aae25
record_format	dspace
spelling	oai:doaj.org-article:176357faa9ec4fb7bc0edb19b50aae252021-11-04T04:45:38ZImpact of COVID-19 pandemic on pharmaceutical systems and supply chain – a phenomenological study2667-276610.1016/j.rcsop.2021.100037https://doaj.org/article/176357faa9ec4fb7bc0edb19b50aae252021-06-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2667276621000378https://doaj.org/toc/2667-2766Background: Resilient pharmaceutical systems and supply chains are critical in the control of COVID-19, a pandemic that has mostly devastated public health systems and livelihoods in resource-limited countries in sub-Saharan Africa. Objective: To evaluate the impact of COVID-19 on pharmaceutical systems and supply chain in a resource-limited setting. Methods: A descriptive qualitative survey using a phenomenological approach was conducted among key informants in the public and private pharmaceutical sectors of Namibia. Data were collected on the perceived impact of COVID-19 pandemic on the supply chain, as well as access and availability of essential medicines among the distributors and points of care in the private and public sectors. Qualitative themes of the impact were analyzed using Tesch's approach. Results: Of the 21 key-informants, 57.1% were female and 85% were from the private versus the public pharmaceutical sector. Overall, key informants reported a negative impact on access and availability of essential medicines, particularly sanitation and hygiene products, and antimicrobials. Most medicine outlets, experienced longer lead times, attributed to reduced inter-country transportation of goods and services and limited in-country capacity and capabilities to manufacture. The main thematic challenges included bureaucratic bottlenecks and lack of emergency readiness of the medicine's logistics supply chain in Namibia. Conclusion: COVID-19 pandemic aggravated the inequitable access to essential medicines in the public and private sectors of Namibia. Governments in resource-limited countries need to strengthen in-country Private-Public Partnerships as well as regional treaties for Universal Health Coverage in context of the COVID-19 pandemic.Tafadzwa Tirivangani, BPharmBertha Alpo, BPharmDan Kibuule, BPharm; MSc; PhDJohannes Gaeseb, BPharm; MPHBabafunso A. Adenuga, BPharm; MPH; PhDElsevierarticleCOVID-19PandemicPharmaceutical sectorLockdownsPharmacy and materia medicaRS1-441ENExploratory Research in Clinical and Social Pharmacy, Vol 2, Iss , Pp 100037- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	COVID-19 Pandemic Pharmaceutical sector Lockdowns Pharmacy and materia medica RS1-441
spellingShingle	COVID-19 Pandemic Pharmaceutical sector Lockdowns Pharmacy and materia medica RS1-441 Tafadzwa Tirivangani, BPharm Bertha Alpo, BPharm Dan Kibuule, BPharm; MSc; PhD Johannes Gaeseb, BPharm; MPH Babafunso A. Adenuga, BPharm; MPH; PhD Impact of COVID-19 pandemic on pharmaceutical systems and supply chain – a phenomenological study
description	Background: Resilient pharmaceutical systems and supply chains are critical in the control of COVID-19, a pandemic that has mostly devastated public health systems and livelihoods in resource-limited countries in sub-Saharan Africa. Objective: To evaluate the impact of COVID-19 on pharmaceutical systems and supply chain in a resource-limited setting. Methods: A descriptive qualitative survey using a phenomenological approach was conducted among key informants in the public and private pharmaceutical sectors of Namibia. Data were collected on the perceived impact of COVID-19 pandemic on the supply chain, as well as access and availability of essential medicines among the distributors and points of care in the private and public sectors. Qualitative themes of the impact were analyzed using Tesch's approach. Results: Of the 21 key-informants, 57.1% were female and 85% were from the private versus the public pharmaceutical sector. Overall, key informants reported a negative impact on access and availability of essential medicines, particularly sanitation and hygiene products, and antimicrobials. Most medicine outlets, experienced longer lead times, attributed to reduced inter-country transportation of goods and services and limited in-country capacity and capabilities to manufacture. The main thematic challenges included bureaucratic bottlenecks and lack of emergency readiness of the medicine's logistics supply chain in Namibia. Conclusion: COVID-19 pandemic aggravated the inequitable access to essential medicines in the public and private sectors of Namibia. Governments in resource-limited countries need to strengthen in-country Private-Public Partnerships as well as regional treaties for Universal Health Coverage in context of the COVID-19 pandemic.
format	article
author	Tafadzwa Tirivangani, BPharm Bertha Alpo, BPharm Dan Kibuule, BPharm; MSc; PhD Johannes Gaeseb, BPharm; MPH Babafunso A. Adenuga, BPharm; MPH; PhD
author_facet	Tafadzwa Tirivangani, BPharm Bertha Alpo, BPharm Dan Kibuule, BPharm; MSc; PhD Johannes Gaeseb, BPharm; MPH Babafunso A. Adenuga, BPharm; MPH; PhD
author_sort	Tafadzwa Tirivangani, BPharm
title	Impact of COVID-19 pandemic on pharmaceutical systems and supply chain – a phenomenological study
title_short	Impact of COVID-19 pandemic on pharmaceutical systems and supply chain – a phenomenological study
title_full	Impact of COVID-19 pandemic on pharmaceutical systems and supply chain – a phenomenological study
title_fullStr	Impact of COVID-19 pandemic on pharmaceutical systems and supply chain – a phenomenological study
title_full_unstemmed	Impact of COVID-19 pandemic on pharmaceutical systems and supply chain – a phenomenological study
title_sort	impact of covid-19 pandemic on pharmaceutical systems and supply chain – a phenomenological study
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/176357faa9ec4fb7bc0edb19b50aae25
work_keys_str_mv	AT tafadzwatirivanganibpharm impactofcovid19pandemiconpharmaceuticalsystemsandsupplychainaphenomenologicalstudy AT berthaalpobpharm impactofcovid19pandemiconpharmaceuticalsystemsandsupplychainaphenomenologicalstudy AT dankibuulebpharmmscphd impactofcovid19pandemiconpharmaceuticalsystemsandsupplychainaphenomenologicalstudy AT johannesgaesebbpharmmph impactofcovid19pandemiconpharmaceuticalsystemsandsupplychainaphenomenologicalstudy AT babafunsoaadenugabpharmmphphd impactofcovid19pandemiconpharmaceuticalsystemsandsupplychainaphenomenologicalstudy
_version_	1718445193827450880

Impact of COVID-19 pandemic on pharmaceutical systems and supply chain – a phenomenological study

Ejemplares similares